Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 25.
doi: 10.1111/hiv.70087. Online ahead of print.

Cellular and humoral response after mRNA SARS-CoV-2 vaccination in kidney transplant recipients living with HIV: A cross-sectional study

Judit Cacho  1   2 , Daniel K Nomah  3 , Natalia Egri  4 , Frederic Cofán  1 , María Ángeles Marcos  5 , María-Mar Mosquera  5 , Sonsoles Sanchez-Palomino  6   7 , Andreu Bruguera  3   8 , Nuria Esforzado  1 , Marta Bodro  6   7 , Cristina Rovira  7 , Carmen Hurtado  7 , Anna Vilella  9 , Fritz Diekmann  1   10 , Asunción Moreno  7 , José M Miro  6   7   11 , David Cucchiari  1   10 ; COVIHVAC investigators
Collaborators, Affiliations

Cellular and humoral response after mRNA SARS-CoV-2 vaccination in kidney transplant recipients living with HIV: A cross-sectional study

Judit Cacho et al. HIV Med. .

Abstract

Introduction: No data exists on responses to mRNA vaccines in kidney transplant recipients (KTRs) with HIV. We compared these responses in HIV-positive (HIV+KTR+) and negative KTRs (HIV-KTR+), and in people living with HIV (PLWH) without kidney transplantation (HIV+KTR-).

Methods: In across-sectional study of 33 patients receiving mRNA SARS-CoV-2 vaccination, we evaluated the humoral response to mRNA SARS-CoV-2 vaccination using a Luminex platform (IgG and IgM), and cellular response with specific T cell response (S-and N- protein) by ELISpot. We used logistic regression models to assess associated factors.

Results: The study comprised 11 HIV-KTR+, 11 HIV+KTR+, and 11 HIV+KTR-. PLWH had suppressed viral load on ART. Seroconversion rates were 72.7% among KTRs, with no significant differences between HIV-KTR+ (81.8%) and HIV+KTR+ (63.6%) (P = 0.338). In HIV+KTR-, seroconversion was 100%, higher than HIV+KTR+ (P = 0.027). Cellular response against protein S occurred in 63.6% of cases, regardless of HIV, transplantation, or dose number. Higher age negatively influenced cellular response in HIV+KTR- (OR 0.77, 95%CI 0.60-0.99).

Conclusion: Although cellular immune response was similar across all groups, humoral response was reduced in HIV+KTR+. In HIV+KTR-, age reduced cellular response. These findings enhance our understanding of vaccine response in immunosuppressed populations and aid in optimizing vaccination strategies.

Keywords: COVID‐19; HIV; SARS‐CoV‐2 vaccine; cellular response; humoral response; immunosuppression; kidney transplant; mRNA vaccine.

PubMed Disclaimer

References

REFERENCES

    1. World Health Organization. WHO Coronavirus Disease (COVID‐19) Dashboard. 2023 https://covid19.who.int/ Accessed July 11, 2023.
    1. Jackson LA, Anderson EJ, Rouphael NG, et al. An mRNA vaccine against SARS‐CoV‐2—preliminary report. N Engl J Med. 2020;383:1920‐1931.
    1. Walsh EE, Frenck RW Jr, Falsey AR, et al. Safety and immunogenicity of two RNA‐based Covid‐19 vaccine candidates. N Engl J Med. 2020;383:2439‐2450.
    1. Caillard S, Chavarot N, Francois H, et al. Is COVID‐19 infection more severe in kidney transplant recipients? Am J Transplant. 2021;21:1295‐1303.
    1. Candon S, Thervet E, Lebon P, et al. Humoral and cellular immune responses after influenza vaccination in kidney transplant recipients. Am J Transplant. 2009;9:2346‐2354.